The Nutshell

» cancer and funding

Daily News Roundup

Most Recent

image: Oxford University to Study Marijuana

Oxford University to Study Marijuana

By | March 20, 2017

Academics partner with a biotech firm to investigate cannabinoids and develop potential therapeutics.

0 Comments

image: Tasmanian Devil Cancer Immunotherapy

Tasmanian Devil Cancer Immunotherapy

By | March 13, 2017

Researchers in Australia claim to have successfully used immunotherapy to treat devil facial tumor disease.

0 Comments

image: Henrietta Lacks’s Family Seeks Compensation

Henrietta Lacks’s Family Seeks Compensation

By | February 16, 2017

Family members of Lacks, the donor behind the widely used HeLa cell line, are planning to sue Johns Hopkins University.

1 Comment

The tumor biologist’s landmark discovery provided the first clear evidence that genetic mutations could lead to cancer, and gave rise to a crucial cancer drug.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: MD Anderson Cancer Center’s Losses Grow

MD Anderson Cancer Center’s Losses Grow

By | December 13, 2016

The first two months of the fiscal year saw $102.4 million in operating losses.

1 Comment

In a pair of clinical studies of psilocybin, the active ingredient in magic mushrooms, participants reported positive changes to their moods and outlooks.

1 Comment

image: First CRISPR Clinical Trial Commences

First CRISPR Clinical Trial Commences

By | November 15, 2016

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

0 Comments

image: Amyloid Designed to Inactivate Cancer-Related Protein

Amyloid Designed to Inactivate Cancer-Related Protein

By | November 14, 2016

Researchers build a peptide that causes a receptor to form toxic, amyloid-like clumps in cells.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Inflammation Drives Gut Bacteria Evolution
  4. Women Lose Vision After Stem Cell Treatment
Business Birmingham